Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer
Clinical trial NCT00260364 · COMPLETED
Trial details
- NCT number
- NCT00260364
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2011-08-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.